590 material Form 8-K filings that 521 companies we cover made with the SEC in October 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Kadant reported third-quarter 2024 revenue of $271.6 million, up 11% from a year earlier, though organic revenue fell 1% excluding acquisitions. Net income attributable to Kadant rose 2% to $31.6 million, and adjusted EPS rose 6% to $2.84. The company raised its 2024 adjusted EPS guidance to $9.93 to $10.13 and narrowed its revenue guidance to $1.047 to $1.055 billion.
Q3 revenue $271.6 million, up 11%; organic revenue down 1%, with acquisitions adding 12%
Net income $31.6 million, up 2%; GAAP diluted EPS $2.68, up 2%; adjusted EPS $2.84, up 6%
2024 adjusted EPS guidance raised to $9.93 to $10.13 from $9.80 to $10.05
2024 revenue guidance narrowed to $1.047 to $1.055 billion from $1.045 to $1.065 billion
Chemed reported third-quarter 2024 revenue of $606.2 million, up 7.4%, and adjusted diluted EPS of $5.64, up 6.0%. The company said Roto-Rooter's revenue and adjusted EBITDA were softer than anticipated, and it revised full-year 2024 adjusted EPS guidance to $23.00 to $23.15, which implies a 13.3% to 14.0% increase over 2023's $20.30.
Q3 2024 revenue $606.2 million, up 7.4%; GAAP diluted EPS $5.00, up 1.4%; adjusted diluted EPS $5.64, up 6.0%
VITAS net patient revenue $391.4 million, up 17.3%; Roto-Rooter revenue $214.8 million, down 6.9%
Roto-Rooter adjusted EBITDA $56.4 million, down 15.8%; adjusted EBITDA margin 26.3%, down 275 basis points
Full-year 2024 adjusted EPS guidance $23.00 to $23.15; company repurchased 100,000 shares for $57.8 million in the quarter
FirstEnergy reported third quarter 2024 GAAP earnings from continuing operations of $419 million, or $0.73 per share, on revenue of $3.7 billion, and operating earnings of $0.85 per share, within its guidance range. The company narrowed its full-year 2024 operating earnings guidance to $2.61 to $2.71 per share, lowering the top of the prior $2.61 to $2.81 range, and raised its 2024 capital investment plan to $4.6 billion.
Q3 2024 GAAP earnings from continuing operations were $419 million ($0.73 per share), compared with $421 million ($0.74 basic per share) in Q3 2023.
Q3 2024 operating EPS was $0.85, down from $0.88 in Q3 2023, while revenue rose to $3.7 billion from $3.5 billion.
2024 operating EPS guidance narrowed to $2.61 to $2.71 from $2.61 to $2.81, citing mild weather, lower Ohio distribution revenues and higher storm restoration costs.
The 2024 capital investment plan increased by $300 million to $4.6 billion, and the company affirmed its targeted 6% to 8% long-term annual operating earnings growth.
EXL reported third-quarter 2024 revenue of $472.1 million, up 14.9% from a year earlier, and GAAP diluted EPS of $0.33, up 24.2%. The company raised its full-year 2024 guidance for revenue to $1.825 billion to $1.835 billion and for adjusted diluted EPS to $1.61 to $1.63, which gives shareholders a higher outlook than before.
Q3 2024 revenue was $472.1 million, up 14.9% year over year and up 5.3% sequentially on a reported basis.
Q3 2024 GAAP diluted EPS was $0.33, up from $0.26 in Q3 2023; adjusted diluted EPS was $0.44, up from $0.37.
Full-year 2024 revenue guidance was raised to $1.825 billion to $1.835 billion, from $1.805 billion to $1.830 billion.
Full-year 2024 adjusted diluted EPS guidance was raised to $1.61 to $1.63, from $1.59 to $1.62.
InvenTrust reported third-quarter 2024 results on October 29, 2024, with Nareit FFO of $0.45 per diluted share and Core FFO of $0.44, both up from $0.41 a year earlier. The company raised the low end of its full-year Nareit FFO guidance to $1.74 from $1.73 and its Core FFO guidance to $1.70 to $1.73 from $1.69 to $1.73, which points to higher expected per-share operating results for shareholders.
Q3 Nareit FFO was $30.9 million, or $0.45 per diluted share, versus $0.41 in Q3 2023
Same Property NOI rose 6.5% to $45.5 million for the quarter
Full-year Core FFO guidance is now $1.70 to $1.73 per diluted share, up from $1.69 to $1.73
Net loss narrowed to $0.5 million, or $0.01 per share, from $0.8 million a year earlier
CTS reported third-quarter 2024 sales of $132 million, down 2% from a year earlier, while net income rose to $19 million from $14 million and diluted EPS reached $0.61 versus $0.44. The company lowered its full-year 2024 sales guidance to $515 million-$525 million from $525 million-$540 million, but kept its adjusted diluted EPS guidance of $2.05-$2.25, so shareholders face weaker revenue expectations even as profitability improved.
Q3 2024 sales were $132 million, down 2% year over year, and net income was $19 million, or 14% of sales.
Diluted EPS was $0.61 versus $0.44 a year earlier; adjusted diluted EPS was $0.63 versus $0.54.
Full-year 2024 sales guidance was cut to $515 million-$525 million from $525 million-$540 million.
Adjusted diluted EPS guidance of $2.05-$2.25 was reiterated; operating cash flow rose to $35 million from $22 million.
Crocs reported third-quarter 2024 revenue of $1,062 million, up 1.6%, and GAAP diluted earnings per share of $3.36, up 17.1%. The company lowered its full-year HEYDUDE revenue outlook to a decline of about 14.5%, from a prior range of down 8% to 10%, and now expects overall 2024 revenue growth at the lower end of its 3% to 5% range, which weighs on the outlook for shareholders.
Q3 revenue $1,062 million, up 1.6%; GAAP diluted EPS $3.36, up 17.1%; adjusted diluted EPS $3.60, up 10.8%
HEYDUDE Brand Q3 revenue fell 17.4% to $204 million; full-year 2024 HEYDUDE revenue now expected to fall about 14.5%
Full-year 2024 adjusted diluted EPS guidance of $12.82 to $12.90, at the high end of the prior $12.45 to $12.90 range
Q4 2024 adjusted diluted EPS expected at $2.20 to $2.28; the company repaid $110 million of debt in the quarter
Armstrong World Industries reported third-quarter 2024 net sales of $386.6 million, up 11.3%, and diluted net earnings per share of $1.75, up 12.2%. The company raised its full-year 2024 guidance for adjusted EBITDA, adjusted diluted earnings per share and adjusted free cash flow, and narrowed its sales outlook, which matters to shareholders because it signals higher expected profit for the year.
Q3 net sales were $386.6 million versus $347.3 million a year earlier; net earnings were $76.9 million versus $69.5 million.
2024 adjusted diluted EPS guidance is $6.15 to $6.25; 2024 adjusted EBITDA guidance is $482 million to $490 million.
The company repurchased shares for $15 million in Q3 and had $677 million remaining under its authorization as of September 30, 2024.
Nine-month diluted EPS was $4.61, up from $3.93 a year earlier.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.